1.Revascularization of occlusive arterial disease in the lower extremity with the transluminal endarterectomy catheter(TEC).
Jae Kyu KIM ; Jeong Jin SEO ; Byung Kwan KOH ; Hyun De CHUNG
Journal of the Korean Radiological Society 1992;28(2):211-214
Revascularizations of 14 occlusive arterial diseases in the lower extremities with the Transluminal Endarterectomy Catheter was done successfully. The causes of occlusions were atherosclerosis in 9 cases and cardiogenic thromboembolism in 5 cases. The site of lesions were at the common femoral artery in 1 case, the superficial femoral artery in 6 cases and the popliteal artery in 7 cases. The length of the lesion were below 5cm(n=3), 5-10cm(n=2), 11-20cm(n=6) and 21-30cm(n=3). Complications were distal embolism(n=1) and hematoma at the puncture site(n=1). No symptoms recurred in any cases during 2 months -15 months followup. Endarterectomy with Transluminal Endarterectomy Catheter was found to be an effective method for revasculizations of occlusive arterial disease in the lower extremity, especially in long segmental occlusion.
Atherosclerosis
;
Catheters
;
Endarterectomy*
;
Femoral Artery
;
Follow-Up Studies
;
Hematoma
;
Lower Extremity*
;
Methods
;
Popliteal Artery
;
Punctures
;
Thromboembolism
2.Syndrome of Inappropriate Secretion of Antidiuretic Hormone(SIADH) in Acute Respiratory Diseases.
Young Jee KIM ; Young Yull KOH ; Jeong Kee SEO ; Hung Ko MOON
Journal of the Korean Pediatric Society 1987;30(9):1021-1028
No abstract available.
3.A Case of Kasabach-Merritt Syndrome.
Byong Lae KIM ; Jeong Seo KOH ; Woan Chul SUH ; Jae Kon KO
Journal of the Korean Pediatric Society 1987;30(5):577-582
No abstract available.
Kasabach-Merritt Syndrome*
4.Expression of Several Cell Cycle Regulatory Genes in Cultured AT-1 Cardiomyocytes after Formation of Synchronously Beating Sheets.
Kyung Keun KIM ; Chang Weon OH ; Kook Heon SEO ; Jeong Tae KOH
Korean Circulation Journal 1998;28(4):611-619
BACKGROUND AND OBJECTIVE: AT-1 cells have been derived from the left atrial tissue in which the ANF promoter targeted SV40 large T antigen expression. When cultured, clusters of spontaneously contracting cells were observed after 4-5 days and contiguous sheets of synchronously beating cardiomyocytes were formed after 10 days. In this study, expression of several cell cycle regulatory genes were monitored through Northern blot analyses in AT-1 cells during beating and after formation of beating sheets (BS). MATERIALS AND METHOD: AT-1 RNAs were obtained in 3 days after plating, during beating and after formation of BS, and used for Northern blot analyses. RESULTS: alpha-Cardiac myosin heavy chain expression was prominent in beating cells, as would be expected for this contractile protein isoform but ANF was decreased after beating. Gax was not expressed in cultured AT-1 cells but in AT-1 tumor and murine heart. p53 and p21 were decreased after beating which indicate transcription level of p53 and p21 correlated well in AT-1 cells. In contrast, pRB and p107 were increased after beating but p68 (2.4 kb) which arose by alternative splicing of p107 and lacks the pocket domain B was decreased in beating cells. pTCS2, murine tuberous sclerosis gene, represented similar levels during beating but a little was decreased after formation of BS. mRAD50, the murine homologue of yeast DNA recombinational repair gene RAD50, was increased in beating cells, a similar pattern to p107 and pRB. But the p50 arose by alternative splicing of mRAD50 and has 3' half of mRAD50 had unexpectedly appeared and maintained after beating. CONCLUSION: The expression of cell cycle regulatory genes after beating and formation of BS in AT-1 cells showed gene-specific pattern and the p50 which has homology to the mRAD50 may participate in differentiation of cardiomyocytes.
Alternative Splicing
;
Antigens, Viral, Tumor
;
Atrial Natriuretic Factor
;
Blotting, Northern
;
Cell Cycle*
;
Genes, Regulator*
;
Heart
;
Myocytes, Cardiac*
;
Myosin Heavy Chains
;
Recombinational DNA Repair
;
RNA
;
Tuberous Sclerosis
;
Yeasts
5.Pyogenic Arthritis in Renal Transplant Recipients.
Jung Man KIM ; Chang Whan HAN ; Jeong Tae SEO ; Byung Kee BANG ; Yong Bok KOH
The Journal of the Korean Orthopaedic Association 1997;32(3):689-696
Acute pyogenic arthritis in renal transplant patient is one of the serious problem resulting in significant morbidity and mortality. The purpose of this paper is to analyze seven patients in whom acute pyogenic arthritis developed following renal transplantation. Pyogenic arthritis developed in seven (0.7%) out of 958 renal transplant patients whose transplanted kidney functioned well for more than two years. The age of the patients ranged from 37 to 65 years with a mean of 48 years. All patients were male. Pyogenic arthritis developed between the period of one and 12 years (mean: 4.5+/-4.2 years) following transplantation. Causative organisms were Staphylococcus aureus (three), E. coli (two), Salmonella (one) and Acinetobacter bananii (one). Involved joints were four knees, one hip, one elbow and one finger. Two patients improved on a conservative regimen of bed rest and antibiotics and five patients required open drainage. However, pyogenic arthritis recurred in three years, four years and seven years after renal transplant in one patient. Looking at the probable risk factors of age, sex, immunosuppresants, diabetics and acute graft rejection, diabetics and older age (over 40 years old) are highly associated with post renal transplant pyogenic arthritis.
Acinetobacter
;
Anti-Bacterial Agents
;
Arthritis*
;
Bed Rest
;
Drainage
;
Elbow
;
Fingers
;
Graft Rejection
;
Hip
;
Humans
;
Joints
;
Kidney
;
Kidney Transplantation
;
Knee
;
Male
;
Mortality
;
Risk Factors
;
Salmonella
;
Staphylococcus aureus
;
Transplantation*
6.The Treatment of Angiofibromas Using Multiple-Drilling Method by Carbon Dioxide Laser.
Jong Keun SEO ; Sung Hwan HWANG ; Jeong Nan KANG ; Soon Kwon HONG ; Jai Kyoung KOH ; Sung Ho YOON
Korean Journal of Dermatology 2012;50(8):757-759
No abstract available.
Angiofibroma
;
Carbon
;
Carbon Dioxide
;
Lasers, Gas
7.Comparison of CO2 DSA and Conventional Angiography Using Non-ionic Contrast IVledia in Lower Extremity Angiography.
Heoung Keun KANG ; Jeong Jin SEO ; Jae Kyu KIM ; Hyon De CHUNG ; Sung Jae PARK ; Seok Wan KOH
Journal of the Korean Radiological Society 1994;31(5):825-830
PURPOSE: The purpose of this study is to compare CO2 DSA and nonionic contrast media angiography in respect to the quality of the opacification of collaterals and incidence of side-effects in peripheral occlusive arterial disease. MATERIALS AND METHODS: Sixteen patients who were suspected to have peripheral occlusive arterial disease were performed angiography with nonionic contrast media and CO2 at the same location with the same catheter. The causes of the lesions were atherosclerosis(n=7) and Buerger's disease(n:9). CO2 DSA was compared with nonionic contrast media angiography in respect to the quality of image in the diagnosis of the lesions, opacifications of collaterals and side-effects. RESULTS: In atherosclerosis;quality of the images of CO2 DSA was same as that of nonionic contrast media angiography in 6 patients and was poor in 1 patient;opacifications of collaterals of CO2 DSA were same as that of nonionic contrast media angiography in 5 patients and was poor in 2 patients. In Buerger's disease;quality of the images of CO2 DSA was same as that of nonionic contrast media angiography in 2 patients and was poor in 7 patients;opacifications of collaterals of CO2 DSA were same as that of nonionic contrast media angiography in 1 patient and was poor in 8 patients. Leg pain was the only side-effect after CO2 injection occuring in 4 out of 16 patients. CONCLUSION: CO2 could be used as safe contrast media in patient with risk factors for nonionic contrast media and for diagnosis of the atherosclerosis in lower extremity. For the procedures such as vascular intervention reguiring large amount of contrast media CO2 could effectively replace nonionic contrast media.
Angiography*
;
Atherosclerosis
;
Catheters
;
Contrast Media
;
Diagnosis
;
Humans
;
Incidence
;
Leg
;
Lower Extremity*
;
Risk Factors
8.Langerhans Cell Microgranulomas.
Young Seok LEE ; Jeong Nan KANG ; Sung Hwan HWANG ; Youn Mee KIM ; Jong Keun SEO ; Jai Kyoung KOH
Korean Journal of Dermatology 2013;51(1):76-78
No abstract available.
Dermatitis, Allergic Contact
9.Detection of A-V shunting with CO2-DSA in hepatocellular carcinoma.
Byung Kwan KOH ; Jae Kyu KIM ; Jin Yeob KIM ; Tae Woong CHUNG ; Jeong Jin SEO ; Heoung Keun KANG
Journal of the Korean Radiological Society 1993;29(5):1015-1019
The presence of A-V shunting in hepatocellular carcinoma is an important factor for deciding the prognosis and in the management with transarterial chemoembolization. Twenty-four patients with hepatocellular carcinoma performed with CO2-DSA and iodinated-DSA were reviewed for the evaluation of visibility of A-V shunting. It was classified by the visibility into clearly visible, faintly visible and invisible. Also the authors evaluated neovascularity and tumor staining. And we checked side effects after the injection of CO2 gas during CO2-DSA. A-V shunting was noted in 19 cases(63%), which were clearly visible in 15 of 19 cases(79%) on CO2-DSA and in 7 of 19 cases(37%) on iodinated-DSA. In 3 cases, A-V shunting was noted only on CO2-DSA. CO2-DSA(17%)was inferior to iodinated-DSA in detection of neovasculaity and tumor staining. Side effects from CO2-DSA were abdominal pain(1 case) and chest discomfort(1 case) but improved within several minutes. In conclusion, CO2-DSA is a sensitive and effective method for the detection of A-V shunting in hepatoma.
Carcinoma, Hepatocellular*
;
Humans
;
Methods
;
Prognosis
;
Thorax
10.Therapeutic Efficacy of Dual Therapy and Triple Therapy for Helicobacter pylori Infection in Children.
Sun Hwan BAE ; Jae Sung KOH ; Jeong Kee SEO
Journal of the Korean Pediatric Society 1998;41(3):323-330
PURPOSE: An optimal treatment for Helicobacter pylori (H. pylori) infection in children has not yet been established. In this study, the efficacy and the tolerability of triple therapy with colloidal bismuth subcitrate (CBS), amoxicillin and metronidazole, were evaluated in comparison with dual therapy with CBS and amoxicllin. METHODS: Eighty-six children with H. pylori infection, aged 6 years to 14 years, were enrolled in this study. H. pylori infection was confirmed by endoscopic antral biopsy with an rapid urease test, culture and a modified Giemsa stain. The children were considered positive for H. pylori infection if culture was positive or if both modified Giemsa staining and CLO test were positive. The children were treated with one of the following three regimens. Dual therapy with CBS for 4 weeks and amoxicillin for 2 weeks (Group I. n=57: 1993.8-1995.1), Triple therapy with CBS for 4 weeks, amoxcillin for 2 weeks and metronidazole for 2 weeks (Group IIa. n=11: 1995.2-1995.7), and Triple therapy with CBS for 2 weeks, amoxicillin for 2 weeks and metronidazole for 2 weeks (Group IIb. n=18 : 1995. 8-1996. 6). A 50mg/kg/d dose of amoxcillin was aclministered, and that of CBS was 7-8mg/kg/d, and that of metronidazole was 20mg/kg/d. About one month after the cessation of treatment, eradication of H. pylori was evaluated with repeated endoscopic biopsy. RESULTS: H. pylori eradication rate was 61.4% (35/57) in Group I, 90.9% (10/11) in Group IIa, and in the absence of H. pylori 88.9% (16/18) of Group IIb was done by means of an urease test, culture and a modified Giemsa stain (P=0.012). The overall proportion of eradication of H. pylori infection was 89.7% (26/29) by triple therapy and 61.4% (35/57) by dual therapy (P=0.007). However, there was no statistically significant difference in eradication rate between the 2-week triple therapy (IIb) and the Denol 4-week triple therapy (IIa)(P=0.86). Side effects : All patients in three treatment groups were tolerated well with little and mild side effects (P=0.258). CONCLUSION: The 2-week triple therapy with CBS, amoxcillin, and metronidazole would be a highly effective and safe treatment regimen for H. pylori infection in children.
Amoxicillin
;
Azure Stains
;
Biopsy
;
Bismuth
;
Child*
;
Colloids
;
Helicobacter pylori*
;
Helicobacter*
;
Humans
;
Metronidazole
;
Urease
;
Withholding Treatment